R

Revvity Inc
NYSE:RVTY

Watchlist Manager
Revvity Inc
NYSE:RVTY
Watchlist
Price: 112.34 USD 0.06% Market Closed
Market Cap: 13.7B USD
Have any thoughts about
Revvity Inc?
Write Note

Revvity Inc
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Revvity Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
R
Revvity Inc
NYSE:RVTY
Intangible Assets
$2.8B
CAGR 3-Years
-13%
CAGR 5-Years
18%
CAGR 10-Years
21%
Thermo Fisher Scientific Inc
NYSE:TMO
Intangible Assets
$16.3B
CAGR 3-Years
11%
CAGR 5-Years
3%
CAGR 10-Years
1%
Danaher Corp
NYSE:DHR
Intangible Assets
$19.9B
CAGR 3-Years
-5%
CAGR 5-Years
12%
CAGR 10-Years
12%
Mettler-Toledo International Inc
NYSE:MTD
Intangible Assets
$262.5m
CAGR 3-Years
-3%
CAGR 5-Years
5%
CAGR 10-Years
9%
Agilent Technologies Inc
NYSE:A
Intangible Assets
$547m
CAGR 3-Years
-18%
CAGR 5-Years
-13%
CAGR 10-Years
-2%
IQVIA Holdings Inc
NYSE:IQV
Intangible Assets
$4.7B
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
32%
No Stocks Found

Revvity Inc
Glance View

Market Cap
13.7B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

In the fast-evolving landscape of life sciences and diagnostics, Revvity Inc. stands as a vital player, driving innovation and delivering critical solutions to a diverse array of sectors. Established with a focus on precision, Revvity leverages its expertise in diagnostics and scientific services to address pressing global health challenges. The company operates by providing advanced analytical instruments, reagents, and software, enabling researchers and healthcare providers to conduct intricate analyses with unmatched reliability. Their offerings are crucial in areas such as prenatal and neonatal screening, as well as infectious disease detection, where accuracy is of paramount importance. Revenue generation at Revvity hinges on a hybrid model that includes product sales, service contracts, and licensing. By supplying state-of-the-art laboratory equipment, along with complementary services and software, the company creates a comprehensive ecosystem for research and diagnostic testing. The breadth of their portfolio appeals to a varied clientele, from hospital labs to large research institutions, ensuring a steady and diversified income stream. Furthermore, their commitment to research and development fosters long-term partnerships and secures their place at the forefront of scientific advancement, making Revvity a linchpin in both the healthcare and scientific communities.

RVTY Intrinsic Value
106.53 USD
Overvaluation 5%
Intrinsic Value
Price
R

See Also

What is Revvity Inc's Intangible Assets?
Intangible Assets
2.8B USD

Based on the financial report for Sep 29, 2024, Revvity Inc's Intangible Assets amounts to 2.8B USD.

What is Revvity Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
21%

Over the last year, the Intangible Assets growth was -10%. The average annual Intangible Assets growth rates for Revvity Inc have been -13% over the past three years , 18% over the past five years , and 21% over the past ten years .

Back to Top